We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New System May Enable at-Home Testing for Sleep Disorders

By LabMedica International staff writers
Posted on 06 Oct 2015
Sleep analysis experts have developed a noninvasive system based on audio recordings for breath sound analysis (BSA) that may help simplify diagnosis of sleep disorders such as obstructive sleep apnea (OSA), at far more convenience and lower cost than polysomnography (PSG), resulting in increased willingness for patients to undergo testing.

"We’ve developed a non-contact, BSA algorithm that provides a reliable estimation of whole-night sleep evaluation for detection of sleep quality, snoring severity, and OSA. More...
It has the potential to reduce the cost and management of sleep disorders,” said study leader Yaniv Zigel, PhD, Dept. Biomedical Engineering, Ben Gurion University (Be'er Sheva, Israel).

PSG requires a full night sleep-center stay and patients are connected to numerous electrodes and sensors to acquire signals and data from electroencephalography (EEG), electrooculography (EOG), electromyography (EMG), and electrocardiography (ECG) tests. The data is processed and visually examined or mathematically transformed manually in order to reveal insights about sleep/wake states and many aspects of physiology. “This procedure is time-consuming, tedious, and costly due to complexity and the need for technical expertise; the market is begging for a better solution,” said first author Eliran Dafna, BGU PhD student.

In the design and validation studies, whole-night breathing sounds were measured from 150 patients using both ambient microphones and PSG simultaneously. The system was trained in a design study on 80 subjects and a validation study was blindly performed on the additional 70 subjects. A set of acoustic features quantifying breathing patterns was developed to distinguish between sleep and wake segments. Sleep quality parameters were calculated based on the sleep/wake classifications and compared with PSG for validity.

When comparing sleep quality parameters, there were only minor average differences between PSG and BSA. Measuring 150,000 individual time segments (epochs), the BSA epoch-by-epoch accuracy rate for the validation study was 83.3% with 92.2% sensitivity measuring sleep-as-sleep, specificity of 56.6% for awake-as-awake, and Cohen's kappa of 0.508.

“The results showed that sleep/wake activity and sleep quality parameters can be reliably estimated solely using BSA,” said coauthor and sleep expert Prof. Ariel Tarasiuk, of BGU and Soroka University Medical Center (Be'er Sheva, Israel). “This study highlights the potential of this innovative approach to measure sleep in research and clinical circumstances. Clearly, the transition of this technology to at-home sleep evaluation depends on third-party reimbursements for the use of home-study equipment.”

The study, by Dafna E et al., was published February 24, 2015, in the journal PLOS ONE.

Related Links:

Ben Gurion University 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.